SLC26A9 and colorectal carcinoma: In contrast, SLC26A9 silencing promoted the apoptosis of human CRC cells but inhibited their migratory functions in vitro and reduced tumor growth in vivo (Fig. 4), suggesting that SLC26A9 may have a proliferative and migratory promoting effect during CRC progression.